Sarcopenic Obesity: How Do We Treat It?

Overview

Journal Curr Opin Endocrinol Diabetes Obes

Specialty Endocrinology

Date 2013 Aug 27

PMID 23974769

Citations 60

Authors

Matthew F Bouchonville

Dennis T Villareal

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The increasing prevalence of sarcopenic obesity in older adults has heightened interest in identifying the most effective treatment. This review highlights recent progress in the management, with an emphasis on lifestyle interventions and pharmacologic therapy aimed at reversing sarcopenic obesity.

Recent Findings: Whereas weight loss and exercise independently reverse sarcopenic obesity, they act synergistically in combination to improve body composition and physical function, beyond which is observed with either intervention alone. Optimizing protein intake appears to have beneficial effects on net muscle protein accretion in older adults. Myostatin inhibition is associated with favorable changes in body composition in animal studies, although experience in humans is relatively limited. Testosterone and growth hormone offer improvements in body composition, but the benefits must be weighed against potential risks of therapy. GHRH-analog therapy shows promise, but further studies are needed in older adults.

Summary: At present, lifestyle interventions incorporating both diet-induced weight loss and regular exercise appear to be the optimal treatment for sarcopenic obesity. Maintenance of adequate protein intake is also advisable. Ongoing studies will determine whether pharmacologic therapy such as myostatin inhibitors or GHRH analogs have a role in the treatment of sarcopenic obesity.

Citing Articles

Rizvi A, Rizzo M Medicina (Kaunas). 2024; 60(10).

PMID: 39459434 PMC: 11509678. DOI: 10.3390/medicina60101648.

Nutritional Management and Physical Activity in the Treatment of Sarcopenic Obesity: A Review of the Literature.

Assyov Y, Nedeva I, Spassov B, Gerganova A, Velikov T, Kamenov Z Nutrients. 2024; 16(15).

PMID: 39125439 PMC: 11314398. DOI: 10.3390/nu16152560.

Effects of Circuit Training Program on Cardiovascular Risk Factors, Vascular Inflammatory Markers, and Insulin-like Growth Factor-1 in Elderly Obese Women with Sarcopenia.

Jung W, Kim Y, Kim J, Park H Rev Cardiovasc Med. 2024; 23(4):134.

PMID: 39076242 PMC: 11273982. DOI: 10.31083/j.rcm2304134.

Combined Nutrition with Exercise: Fueling the Fight Against Sarcopenia Through a Bibliometric Analysis and Review.

Zeng Y, He X, Peng X, Zhao L, Yin C, Mao S Int J Gen Med. 2024; 17:1861-1876.

PMID: 38715745 PMC: 11075762. DOI: 10.2147/IJGM.S462594.

Sarcopenic obesity in older adults: a clinical overview.

Prado C, Batsis J, Donini L, Gonzalez M, Siervo M Nat Rev Endocrinol. 2024; 20(5):261-277.

PMID: 38321142 DOI: 10.1038/s41574-023-00943-z.

References

Grobet L, Martin L, Poncelet D, Pirottin D, Brouwers B, Riquet J . A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet. 1997; 17(1):71-4. DOI: 10.1038/ng0997-71. View

Schirwis E, Agbulut O, Vadrot N, Mouisel E, Hourde C, Bonnieu A . The beneficial effect of myostatin deficiency on maximal muscle force and power is attenuated with age. Exp Gerontol. 2012; 48(2):183-90. DOI: 10.1016/j.exger.2012.11.008. View

Zimmers T, Davies M, Koniaris L, Haynes P, Esquela A, Tomkinson K . Induction of cachexia in mice by systemically administered myostatin. Science. 2002; 296(5572):1486-8. DOI: 10.1126/science.1069525. View

Leger B, Derave W, De Bock K, Hespel P, Russell A . Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation. Rejuvenation Res. 2008; 11(1):163-175B. DOI: 10.1089/rej.2007.0588. View

Lambert C, Wright N, Finck B, Villareal D . Exercise but not diet-induced weight loss decreases skeletal muscle inflammatory gene expression in frail obese elderly persons. J Appl Physiol (1985). 2008; 105(2):473-8. PMC: 2519937. DOI: 10.1152/japplphysiol.00006.2008. View

Zizza C, Herring A, Stevens J, Popkin B . Obesity affects nursing-care facility admission among whites but not blacks. Obes Res. 2002; 10(8):816-23. DOI: 10.1038/oby.2002.110. View

Kim Y, Lee Y, Chung Y, Lee D, Joo N, Hong D . Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012; 67(10):1107-13. DOI: 10.1093/gerona/gls071. View

Garatachea N, Pinos T, Camara Y, Rodriguez-Romo G, Emanuele E, Ricevuti G . Association of the K153R polymorphism in the myostatin gene and extreme longevity. Age (Dordr). 2013; 35(6):2445-54. PMC: 3825013. DOI: 10.1007/s11357-013-9513-3. View

Wing R, Hamman R, Bray G, Delahanty L, Edelstein S, Hill J . Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res. 2004; 12(9):1426-34. PMC: 2505058. DOI: 10.1038/oby.2004.179. View

10.

Giannesini B, Vilmen C, Amthor H, Bernard M, Bendahan D . Lack of myostatin impairs mechanical performance and ATP cost of contraction in exercising mouse gastrocnemius muscle in vivo. Am J Physiol Endocrinol Metab. 2013; 305(1):E33-40. DOI: 10.1152/ajpendo.00651.2012. View

11.

Symons T, Schutzler S, Cocke T, Chinkes D, Wolfe R, Paddon-Jones D . Aging does not impair the anabolic response to a protein-rich meal. Am J Clin Nutr. 2007; 86(2):451-6. DOI: 10.1093/ajcn/86.2.451. View

12.

Hameed U, Manzar D, Raza S, Shareef M, Hussain M . Resistance Training Leads to Clinically Meaningful Improvements in Control of Glycemia and Muscular Strength in Untrained Middle-aged Patients with type 2 Diabetes Mellitus. N Am J Med Sci. 2012; 4(8):336-43. PMC: 3421911. DOI: 10.4103/1947-2714.99507. View

13.

Villareal D, Banks M, Siener C, Sinacore D, Klein S . Physical frailty and body composition in obese elderly men and women. Obes Res. 2004; 12(6):913-20. DOI: 10.1038/oby.2004.111. View

14.

Schrager M, Metter E, Simonsick E, Ble A, Bandinelli S, Lauretani F . Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol (1985). 2006; 102(3):919-25. PMC: 2645665. DOI: 10.1152/japplphysiol.00627.2006. View

15.

Milanovic Z, Pantelic S, Trajkovic N, Sporis G, Kostic R, James N . Age-related decrease in physical activity and functional fitness among elderly men and women. Clin Interv Aging. 2013; 8:549-56. PMC: 3665513. DOI: 10.2147/CIA.S44112. View

16.

Shan T, Liang X, Bi P, Kuang S . Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J. 2013; 27(5):1981-9. PMC: 3633817. DOI: 10.1096/fj.12-225755. View

17.

Rieu I, Balage M, Sornet C, Giraudet C, Pujos E, Grizard J . Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia. J Physiol. 2006; 575(Pt 1):305-15. PMC: 1819434. DOI: 10.1113/jphysiol.2006.110742. View

18.

Wang K, Li Z, Li Y, Zeng J, He C, Yang J . Muscle-specific transgenic expression of porcine myostatin propeptide enhances muscle growth in mice. Transgenic Res. 2013; 22(5):1011-9. DOI: 10.1007/s11248-013-9709-4. View

19.

Frimel T, Sinacore D, Villareal D . Exercise attenuates the weight-loss-induced reduction in muscle mass in frail obese older adults. Med Sci Sports Exerc. 2008; 40(7):1213-9. PMC: 2650077. DOI: 10.1249/MSS.0b013e31816a85ce. View

20.

Blackman M, Sorkin J, Munzer T, Bellantoni M, Busby-Whitehead J, Stevens T . Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002; 288(18):2282-92. DOI: 10.1001/jama.288.18.2282. View